Kannan Kashi Vishwanath
Corporate Officer/Principal bei Indo-American Chamber of Commerce & Industry
Profil
Dr. Kannan Kashi Vishwanath is Vice Chairman & Managing Director at Dr. Datsons Labs Ltd.
and a Member at Indo-American Chamber of Commerce & Industry.
He is on the Board of Directors at Dr. Datsons Labs Ltd.
and Finaventure Capital Ltd.
He received his undergraduate degree from the University of Pune, an MBA from Hamilton College (New York), and a doctorate degree from The International University.
Aktive Positionen von Kannan Kashi Vishwanath
| Unternehmen | Position | Beginn |
|---|---|---|
| Indo-American Chamber of Commerce & Industry | Corporate Officer/Principal | 17.06.2011 |
Ehemalige bekannte Positionen von Kannan Kashi Vishwanath
| Unternehmen | Position | Ende |
|---|---|---|
| FINAVENTURE CAPITAL LTD | Vorstandsvorsitzender | 14.02.2015 |
| DR DATSONS LABS LTD | Gründer | 21.08.2014 |
Ausbildung von Kannan Kashi Vishwanath
| University of Pune | Undergraduate Degree |
| Hamilton College (New York) | Masters Business Admin |
| The International University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Finaventure Capital Ltd.
 Finaventure Capital Ltd. Investment ManagersFinance Finaventure Capital Ltd. is an investment company, which engages in the business of investments in listed and unlisted companies. The company was founded on January 19, 1985 and is headquartered in Mumbai, India. | Finance |
Dr.Datsons Labs Ltd.
 Dr.Datsons Labs Ltd. Pharmaceuticals: MajorHealth Technology Dr. Datsons Labs Ltd. engages in the manufacture, and market of contract research and manufacturing services (CRAMS), and active pharmaceutical ingredients (API). It operates through the following segments: Active Pharmaceutical Ingredients (API), Formulation, and Trading. The API segment manufactures second generation anti-malaria APIs like quinine and salts as well as third generation anti-malarial products like Artemisinin-based salts. The company was founded by Kannan Kashi Vishwanathan on January 3, 2006 and is headquartered in Mumbai, India. | Health Technology |
| Indo-American Chamber of Commerce & Industry |
